US 11,891,381 B2
Compounds for the treatment of glycogen storage disorders
Or Kakhlon, Jerusalem (IL); Miguel Enrique Weil, Tel-Aviv (IL); and Leonardo Javier Solmesky, Yavne (IL)
Assigned to HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD., Jerusalem (IL); and RAMOT AT TEL-AVIV UNIVERSITY LTD., Tel Aviv (IL)
Filed by HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD., Jerusalem (IL); and RAMOT AT TEL-AVIV UNIVERSITY LTD., Tel Aviv (IL)
Filed on May 31, 2021, as Appl. No. 17/334,905.
Application 17/334,905 is a division of application No. 16/485,577, granted, now 11,053,231, previously published as PCT/IL2018/050207, filed on Feb. 22, 2018.
Claims priority of provisional application 62/461,884, filed on Feb. 22, 2017.
Prior Publication US 2021/0395237 A1, Dec. 23, 2021
Int. Cl. C07D 409/12 (2006.01); A61P 25/28 (2006.01); C07D 487/08 (2006.01)
CPC C07D 409/12 (2013.01) [A61P 25/28 (2018.01); C07D 487/08 (2013.01)] 10 Claims
 
1. A method of treating a medical condition associated with accumulation of polyglucosan bodies in a tissue of a subject, the method comprising administering to the subject a pharmaceutical composition comprising a therapeutically effective amount of a compound

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt thereof.